Osmotica Pharmaceuticals Plc OverviewOsmotica Pharmaceuticals Plc Other Income Expense Net
Other Income/Expense Net for OSMT.
Quarterly Other Income/Expense
-$12.72M
↓ 486.16% YoY
As of Jun 30, 2023
Annual Other Income/Expense (TTM)
-$21.81M
↓ 335.73% YoY
Trailing 12 months ending Jun 30, 2023